Late Onset Junctional Epidermolysis Bullosa C4304724
A genetic skin disorder causing blistering that develops later in childhood or adulthood rather than at birth. Wound care and infection prevention are key management strategies.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Late Onset Junctional Epidermolysis Bullosa C4304724?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Has C, Mazzanti C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2020.
Has C, Liu L, Bolling MC, Charlesworth AV, El Hachem M, Escamez MJ, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. Br J Dermatol. 2022.
Mazón MJ, Gau途 MC, Y sustitutos. Late-onset junctional epidermolysis bullosa: clinical features and molecular characterization. Acta Derm Venereol. 2019.
Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podolan M, et al. Molecular genetics of junctional epidermolysis bullosa: mutation spectrum and diagnostic approach. Exp Dermatol. 2021.
Medication Comparisons
Compare medications used to treat Late Onset Junctional Epidermolysis Bullosa C4304724. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy